Phase I/II EPCORE NHL-2
Phase I/II EPCORE NHL-2 Trial Update: Epcoritamab + Rituximab/Lenalidomide in Follicular Lymphoma

Released: December 17, 2022

Expiration: December 16, 2023

Activity

Progress
1
Course Completed